Fangzhou Partners with Cutia Therapeutics for AI-Powered Dermatology Services

GUANGZHOU, China, Oct. 19, 2026 /CourierPR/ -- Fangzhou Inc., a leading provider of AI-driven Internet healthcare solutions (HKEX: 06086), has announced a strategic partnership with Cutia Therapeutics, a company specializing in dermatology and hair-related conditions, to advance AI-powered dermatology and chronic health management services.

The partnership, announced at Fangzhou’s 2026 Double 11 (Single’s Day) Partner Conference in Guangzhou, aims to integrate Cutia’s dermatology expertise with Fangzhou’s digital healthcare capabilities. This collaboration will focus on accelerating access to innovative treatments and developing personalized, long-term patient management services.

Fangzhou, with its extensive user base of 59.8 million registered users and 282,000 physicians, has been expanding its "AI + Chronic Disease Services" model. The company’s proprietary "XingShi" Large Language Model (XS LLM) supports its AI applications, which cover health monitoring, patient follow-up, and health education. These services aim to connect medical treatments with continuous healthcare services beyond individual consultations.

Wang Haijiao, Executive Director and CEO of Fangzhou, emphasized the significance of leveraging Fangzhou’s established AI-powered healthcare capabilities to develop full-cycle management packages tailored to Chinese patients. These packages integrate products, one-on-one follow-up, online assessments, and health guidance into a comprehensive service model.

Zhang Lele, Executive Director and CEO of Cutia Therapeutics, highlighted the substantial unmet clinical needs in dermatological healthcare. She expressed confidence that Fangzhou’s AI technology and digital service capabilities would help bridge the gap between innovative treatments and patients, expanding access to structured, high-quality, and continuous health management.

The partnership is expected to strengthen collaboration across the pharmaceutical and healthcare industries, expanding the application of AI in chronic disease services and developing integrated digital healthcare solutions. This move aligns with the objectives of the Healthy China initiative, which aims to improve public health and healthcare services in China.

By combining Fangzhou’s digital healthcare expertise with Cutia’s dermatology knowledge, the partnership seeks to enhance patient care and treatment outcomes in the dermatology field. The collaboration represents a significant step in leveraging technology to address the growing healthcare needs in China.